ZEPZELCA is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Jazz Pharmaceuticals, Inc.. The primary component is Lurbinectedin.
| Product ID | 68727-712_1539647e-08e6-449a-86f7-0d090dbeb698 |
| NDC | 68727-712 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ZEPZELCA |
| Generic Name | Lurbinectedin |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-06-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA213702 |
| Labeler Name | Jazz Pharmaceuticals, Inc. |
| Substance Name | LURBINECTEDIN |
| Active Ingredient Strength | 1 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2020-06-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ZEPZELCA 88916468 not registered Live/Pending |
PHARMA MAR, S.A. 2020-05-14 |
![]() ZEPZELCA 88848581 not registered Live/Pending |
PHARMA MAR S.A. 2020-03-26 |
![]() ZEPZELCA 88848557 not registered Live/Pending |
PHARMA MAR S.A. 2020-03-26 |